|
DDX17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.91809934391563E-11 |
| Normal-vs-Stage2 |
2.31759944568921E-10 |
| Normal-vs-Stage3 |
1.98896454861597E-12 |
| Normal-vs-Stage4 |
3.79420050933277E-10 |
| Stage1-vs-Stage2 |
1.729600E-02 |
| Stage1-vs-Stage3 |
1.183900E-03 |
| Stage1-vs-Stage4 |
3.813900E-02 |
| Stage2-vs-Stage3 |
7.217400E-01 |
| Stage2-vs-Stage4 |
7.616600E-01 |
| Stage3-vs-Stage4 |
9.697800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.85327317328665E-14 |
| Normal-vs-AfricanAmerican |
1.52386999999754E-05 |
| Normal-vs-Asian |
2.373800E-04 |
| Caucasian-vs-AfricanAmerican |
7.669600E-01 |
| Caucasian-vs-Asian |
3.795600E-02 |
| AfricanAmerican-vs-Asian |
1.422170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.14789988415032E-10 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
3.941200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72640013396119E-10 |
| Normal-vs-Age(41-60Yrs) |
6.21058759975313E-13 |
| Normal-vs-Age(61-80Yrs) |
1.71185288166953E-12 |
| Normal-vs-Age(81-100Yrs) |
1.320680E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.308570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.197200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.512600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.297700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.068200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.659200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.62674999999446E-05 |
| Classical-VS-Follicular |
9.783400E-04 |
| Classical-VS-Other |
8.685400E-01 |
| Classical-VS-Normal |
8.30746582636266E-12 |
| Tall-VS-Follicular |
2.268200E-01 |
| Tall-VS-Other |
3.056000E-01 |
| Tall-VS-Normal |
3.75699471533153E-13 |
| Follicular-VS-Other |
3.959800E-01 |
| Follicular-VS-Normal |
2.81408230051738E-12 |
| Other-VS-Normal |
1.725940E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.59601237676088E-13 |
| Normal-vs-N1 |
1.86114999999321E-05 |
| N0-vs-N1 |
1.857810E-01 |
|
|
